{"id":286589,"date":"2026-10-05T11:37:14","date_gmt":"2026-10-05T06:07:14","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=286589"},"modified":"2026-10-21T10:29:53","modified_gmt":"2026-10-21T04:59:53","slug":"why-natco-pharma-ltd-share-price-near-52-week-low-today-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-natco-pharma-ltd-share-price-near-52-week-low-today-2026\/","title":{"rendered":"Natco Pharma (NATCOPHARM) Share Price near 52-week low: What the latest move means"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/natcopharm\/natco-pharma-ltd-share-price-today\">Natco Pharma Ltd. (NATCOPHARM)<\/a> share price is trading within 2% of its 52-week low today and stood at Rs 785.8, down 1.87% from the previous close. Market cap was Rs 15,708.15 crore.<\/em><\/div>\n<p style=\"margin-top:0!important;\"><strong>Natco Pharma Share Price<\/strong> is trading at Rs 785.80, down 1.87% from the previous close of Rs 800.75, and remains near its 52-week low while market capitalisation stands at Rs 15,708.15 crore. The latest Univest data confirms the price event but does not establish a company-specific catalyst. Still, Natco Pharma Share Price is attracting attention because the move places the stock close to a one-year low, with soft short-term momentum, a lower-than-sector valuation and a market cap that keeps it in the mid-cap healthcare bracket. For readers tracking Natco Pharma Share Price Today, the key question is not only where the stock is trading, but how the price action, technical backdrop and fundamentals fit together in current market conditions.<\/p>\n<p>Natco Pharma Stock News is therefore about more than one red print on the screen. The stock is trading below its 50 DMA of Rs 826.78 and its 200 DMA of Rs 936.09, which keeps the near-term and longer-term trend under pressure. At the same time, the company\u2019s P\/E ratio of 13.73, P\/B ratio of 1.68, ROE of 16.3%, ROCE of 17.16%, EPS of Rs 58.33 and book value of Rs 476.47 provide a useful fundamental anchor. The dividend yield of 0.62% also adds another layer to Natco Pharma Share Price analysis, even as the market continues to weigh price action against sector context and peer comparison.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-natco-pharma-ltd-share-price-near-52-week-low-today-2026\/#Natco_Pharma_Share_Price_Today_Price_Action_Analysis\" title=\"Natco Pharma Share Price Today: Price Action Analysis\">Natco Pharma Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-natco-pharma-ltd-share-price-near-52-week-low-today-2026\/#Natco_Pharma_Ltd_NATCOPHARM_Fundamental_Analysis\" title=\"Natco Pharma Ltd. (NATCOPHARM) Fundamental Analysis\">Natco Pharma Ltd. (NATCOPHARM) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-natco-pharma-ltd-share-price-near-52-week-low-today-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-natco-pharma-ltd-share-price-near-52-week-low-today-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-natco-pharma-ltd-share-price-near-52-week-low-today-2026\/#Why_Investors_Are_Watching_Natco_Pharma\" title=\"Why Investors Are Watching Natco Pharma\">Why Investors Are Watching Natco Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-natco-pharma-ltd-share-price-near-52-week-low-today-2026\/#About_Natco_Pharma\" title=\"About Natco Pharma\">About Natco Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-natco-pharma-ltd-share-price-near-52-week-low-today-2026\/#Track_Natco_Pharma_Share_Price_on_Univest\" title=\"Track Natco Pharma Share Price on Univest\">Track Natco Pharma Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-natco-pharma-ltd-share-price-near-52-week-low-today-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-natco-pharma-ltd-share-price-near-52-week-low-today-2026\/#Why_is_Natco_Pharma_Share_Price_near_a_52-week_low\" title=\"Why is Natco Pharma Share Price near a 52-week low?\">Why is Natco Pharma Share Price near a 52-week low?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-natco-pharma-ltd-share-price-near-52-week-low-today-2026\/#What_is_Natco_Pharma_Share_Price_Today\" title=\"What is Natco Pharma Share Price Today?\">What is Natco Pharma Share Price Today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-natco-pharma-ltd-share-price-near-52-week-low-today-2026\/#How_does_Natco_Pharma_Share_Price_look_on_valuation\" title=\"How does Natco Pharma Share Price look on valuation?\">How does Natco Pharma Share Price look on valuation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-natco-pharma-ltd-share-price-near-52-week-low-today-2026\/#What_do_ROE_and_ROCE_show_for_Natco_Pharma_Share_Price\" title=\"What do ROE and ROCE show for Natco Pharma Share Price?\">What do ROE and ROCE show for Natco Pharma Share Price?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-natco-pharma-ltd-share-price-near-52-week-low-today-2026\/#What_does_EPS_mean_for_Natco_Pharma_Share_Price\" title=\"What does EPS mean for Natco Pharma Share Price?\">What does EPS mean for Natco Pharma Share Price?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-natco-pharma-ltd-share-price-near-52-week-low-today-2026\/#What_does_book_value_indicate_for_Natco_Pharma_Share_Price\" title=\"What does book value indicate for Natco Pharma Share Price?\">What does book value indicate for Natco Pharma Share Price?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-natco-pharma-ltd-share-price-near-52-week-low-today-2026\/#What_is_the_dividend_yield_for_Natco_Pharma_Share_Price\" title=\"What is the dividend yield for Natco Pharma Share Price?\">What is the dividend yield for Natco Pharma Share Price?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-natco-pharma-ltd-share-price-near-52-week-low-today-2026\/#How_does_Natco_Pharma_Share_Price_compare_with_pharma_peers\" title=\"How does Natco Pharma Share Price compare with pharma peers?\">How does Natco Pharma Share Price compare with pharma peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/why-natco-pharma-ltd-share-price-near-52-week-low-today-2026\/#Should_investors_track_Natco_Pharma_Share_Price_on_Univest\" title=\"Should investors track Natco Pharma Share Price on Univest?\">Should investors track Natco Pharma Share Price on Univest?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Natco_Pharma_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Natco Pharma Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 785.8<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 800.75<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs -14.95 (-1.87%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 808.95<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 808.95<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 784.75<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 15,708.15 crore<\/td>\n<\/tr>\n<\/table>\n<p>Natco Pharma Ltd. (NATCOPHARM) traded at Rs 785.8 versus the previous close of Rs 800.75, a fall of 1.87%. The stock opened at Rs 808.95, reached a high of Rs 808.95, touched a low of Rs 784.75.<\/p>\n<p><strong>Natco Pharma Share Price Today<\/strong> shows a weak intraday setup with the stock opening at Rs 808.95, touching a high of Rs 808.95 and a low of Rs 784.75 before last trading at Rs 785.80. That leaves the share below the previous close of Rs 800.75 and down Rs 14.95 on the day. The move keeps Natco Pharma Share Price near its 52-week low and close to the lower end of the day\u2019s range, which is why traders are watching the stock closely in Stock Market Today and Share Market Today conversations.<\/p>\n<p>Because Natco Pharma Share Price is trading only a little above the day\u2019s low, the price action reflects selling pressure rather than strong recovery attempts during the morning session. The company\u2019s market capitalisation of Rs 15,708.15 crore keeps it firmly visible in healthcare market updates, but the near-one-year low setup means price discovery remains the focus. For anyone following Natco Pharma Share Price Live or Natco Pharma Share Price Update, the immediate attention shifts to whether the stock can stabilise around current support and improve its structure from here.<\/p>\n<p>That makes technical analysis especially important for Natco Pharma Share Price today, because the chart is currently doing more of the talking than the headline move itself.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Natco_Pharma_Ltd_NATCOPHARM_Fundamental_Analysis\"><\/span><strong>Natco Pharma Ltd. (NATCOPHARM) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 15,708.15 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.73x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.68x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">16.3%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">17.16%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 58.33<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 476.47<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.62%<\/td>\n<\/tr>\n<\/table>\n<p>Natco Pharma Ltd. (NATCOPHARM) fundamental metrics show P\/E 13.73x, P\/B 1.68x, ROE 16.3%, ROCE 17.16%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>Natco Pharma Ltd. has a market capitalisation of Rs 15,708.15 crore, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 13.73x, P\/B at 1.68x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 16.3% and ROCE of 17.16%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 58.33, book value per share of Rs 476.47, dividend yield of 0.62%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P\/E of 26.98x, median ROE of 11.23%, median ROCE of 13.17%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.73x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">26.98x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">39.41x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0x to 616.89x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.68x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.75x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">16.3%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.23%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">17.16%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.17%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 15,708.15 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 768.75 crore<\/td>\n<\/tr>\n<\/table>\n<p>Natco Pharma Ltd. (NATCOPHARM) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>Natco Pharma Ltd. (NATCOPHARM) has a P\/E ratio of 13.73x, which is below the benchmark median of 26.98x, a difference of -49.11%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Natco Pharma Ltd. (NATCOPHARM) has a ROE of 16.3%, which is above the benchmark median of 11.23%, a difference of +45.15%. Natco Pharma Ltd. (NATCOPHARM) has a ROCE of 17.16%, which is above the benchmark median of 13.17%, a difference of +30.3%.<\/p>\n<p>Track stocks falling to yearly lows through the <a href=\"https:\/\/univest.in\/screeners\/52-week-low\">Univest 52-week-low screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/alivus\/glenmark-life-sciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Glenmark Life Sciences Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ALIVUS<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15,627.58<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">25.92<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.48<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.41<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">24.61<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/eris\/eris-lifesciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Eris Lifesciences Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ERIS<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15,617.8<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">24.25<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.87<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.23<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.47<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/onesource\/onesource-specl-pharma-l-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>ONESOURCE SPECL PHARMA L<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ONESOURCE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15,818.68<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.7<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-1.26<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0.44<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/aplltd\/alembic-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Alembic Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">APLLTD<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15,532.42<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">22.4<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.66<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.35<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.74<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/astrazen\/astrazeneca-pharma-india-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Astrazeneca Pharma India Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ASTRAZEN<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15,108.25<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">89.07<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.71<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">23.02<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">31.24<\/td>\n<\/tr>\n<\/table>\n<p>Natco Pharma Ltd. (NATCOPHARM) has a P\/E ratio of 13.73x compared with the displayed peer median of 24.25x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 16.3% compares with a peer median of 18.41% across the companies shown in the table. ROCE stood at 17.16% versus the displayed peer median of 14.47%, providing a capital-efficiency comparison. Natco Pharma Ltd. (NATCOPHARM) has a market capitalisation of Rs 15,708.15 crore. Among the 5 peers shown, only 1 has a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Natco_Pharma\"><\/span><strong>Why Investors Are Watching Natco Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Natco Pharma Share Price is trading near its 52-week low, keeping the stock on near-term watchlists.<\/li>\n<li>Natco Pharma Share Price Today is below the 50 DMA and 200 DMA, which signals weak chart structure.<\/li>\n<li>Natco Pharma Fundamental Analysis shows P\/E of 13.73 and P\/B of 1.68, both below industry benchmarks.<\/li>\n<li>ROE of 16.3% and ROCE of 17.16% keep the business quality discussion active.<\/li>\n<li>Sector and peer comparison show Natco Pharma Share Price at a valuation discount versus several pharma names.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Natco_Pharma\"><\/span><strong>About Natco Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Natco Pharma Share Price<\/strong> belongs to Natco Pharma Ltd., a healthcare company in the Pharmaceuticals &#038; Drugs industry. The company operates within the Indian pharmaceutical space and is followed for its product and business profile within the sector. For readers tracking Natco Pharma Company News, the stock sits in a segment where earnings quality, product strategy and valuation can matter as much as short-term price action.<\/p>\n<p>On the numbers supplied here, Natco Pharma Share Price is backed by a market capitalisation of Rs 15,708.15 crore, EPS of Rs 58.33 and book value of Rs 476.47. That combination helps frame the business as a meaningful listed pharma name rather than a small speculative counter. Natco Pharma Stock Performance is therefore usually assessed through both price action and fundamentals, especially when the share is moving near a yearly low. Univest readers often use the company overview, sector context and valuation view together when reviewing Natco Pharma Share Price Today.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Natco_Pharma_Share_Price_on_Univest\"><\/span><strong>Track Natco Pharma Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/natcopharm\/natco-pharma-ltd-share-price-today\">Natco Pharma Ltd. (NATCOPHARM) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-low\">Univest 52-week-low screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-low lists and related market analysis.<\/p>\n<p><strong>Natco Pharma Share Price<\/strong> can be tracked on Univest for live price updates, technical indicators, fundamental ratios, shareholding pattern context, 52-week levels and market insights. Natco Pharma Share Price Today is best read alongside chart structure, sector comparison and valuation metrics so that the move is seen in context. Univest brings these elements together in one place for Natco Pharma Share Price, helping readers monitor the stock\u2019s latest price action, stock news and broader market positioning without relying on fragmented updates.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Natco_Pharma_Share_Price_near_a_52-week_low\"><\/span><strong>Why is Natco Pharma Share Price near a 52-week low?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Natco Pharma Share Price is near a 52-week low because it is trading at Rs 785.80, below the previous close of Rs 800.75 and under key moving averages. The latest Univest data does not establish a company-specific catalyst.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Natco_Pharma_Share_Price_Today\"><\/span><strong>What is Natco Pharma Share Price Today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Natco Pharma Share Price Today is Rs 785.80, down 1.87% from the previous close. The stock opened at Rs 808.95, touched Rs 808.95 and moved as low as Rs 784.75 during the morning session.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Natco_Pharma_Share_Price_look_on_valuation\"><\/span><strong>How does Natco Pharma Share Price look on valuation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Natco Pharma Share Price looks relatively lower-valued versus its industry. The P\/E is 13.73 and the P\/B is 1.68, both below the same-industry benchmark median and average. That gives the stock a discounted valuation profile.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_ROE_and_ROCE_show_for_Natco_Pharma_Share_Price\"><\/span><strong>What do ROE and ROCE show for Natco Pharma Share Price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Natco Pharma Share Price is supported by ROE of 16.3% and ROCE of 17.16%. Both sit above the industry median and average, which indicates respectable profitability and capital efficiency for the business.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_EPS_mean_for_Natco_Pharma_Share_Price\"><\/span><strong>What does EPS mean for Natco Pharma Share Price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Natco Pharma Share Price has EPS of Rs 58.33. EPS shows earnings attributable to each share, so this figure helps investors assess the company\u2019s profit generation alongside price and valuation metrics.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_book_value_indicate_for_Natco_Pharma_Share_Price\"><\/span><strong>What does book value indicate for Natco Pharma Share Price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Natco Pharma Share Price has book value of Rs 476.47. Book value per share shows the accounting net worth behind each share, which helps investors compare market price with underlying balance-sheet value.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_dividend_yield_for_Natco_Pharma_Share_Price\"><\/span><strong>What is the dividend yield for Natco Pharma Share Price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Natco Pharma Share Price carries a dividend yield of 0.62%. Dividend yield is historical data and not a payout guarantee, but it adds another context point for income-oriented stock analysis.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Natco_Pharma_Share_Price_compare_with_pharma_peers\"><\/span><strong>How does Natco Pharma Share Price compare with pharma peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Natco Pharma Share Price trades at lower valuation multiples than peers such as Glenmark Life Sciences, Eris Lifesciences and Alembic Pharmaceuticals. It also carries a market cap broadly comparable with several listed pharma names.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Should_investors_track_Natco_Pharma_Share_Price_on_Univest\"><\/span><strong>Should investors track Natco Pharma Share Price on Univest?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors can track Natco Pharma Share Price on Univest for live price updates, technical indicators, fundamental ratios, 52-week levels and sector context. That helps place price action, valuation and peer comparison in one view.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Natco Pharma Ltd. Share Price trades near its 52-week low at Rs 785.8, marking a 1.87% decline today. Market cap stands at Rs 15,708.15 crore.<\/p>\n","protected":false},"author":38,"featured_media":318678,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-286589","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["318678"],"rank_math_title":["Natco Pharma Share Price today near 52-week low: analysis"],"rank_math_description":["Natco Pharma Share Price trades near its 52-week low at Rs 785.80, with RSI weak and valuation, peers and sector context in focus."],"rank_math_focus_keyword":["Natco Pharma Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/natco-pharma-natcopharm-share-price-near-52-week-low-what-the-latest-move-means.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/286589","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=286589"}],"version-history":[{"count":6,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/286589\/revisions"}],"predecessor-version":[{"id":318679,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/286589\/revisions\/318679"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/318678"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=286589"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=286589"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=286589"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}